BioPower Operations Corporation
BOPO · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | -0.17 | 0.00 | 0.00 |
| FCF Yield | 10.18% | -1.19% | 9.12% | 6.73% |
| EV / EBITDA | 84.53 | 0.00 | 0.00 | -33.45 |
| Quality | ||||
| ROIC | 17.56% | 14.32% | 6.65% | 7.12% |
| Gross Margin | 100.00% | 100.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.39 | 0.46 | -1.00 | -1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | 250.03% | -257.25% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 38.94 | 0.00 | 0.00 | -18.59 |
| Interest Coverage | -2.22 | -1.85 | -1.00 | -1.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.21 | 0.00 | 0.00 | 0.00 |